Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $2.9700 (4.03%) ($2.9700 - $2.9700) on Tue. Aug. 2, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.67% (three month average) | RSI | 21 | Latest Price | $2.9700(4.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -10.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) SPLV(45%) EWP(44%) LIT(44%) XBI(44%) XLU(44%) | Factors Impacting ATRA price | ATRA will decline at least -4.835% in a week (0% probabilities). XOP(5%) CEMB(6%) EDOC(7%) BNDX(7%) XRT(8%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.835% (StdDev 9.67%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-87.29(-3039.06%) | Resistance Level | $4.55 | 5 Day Moving Average | $3.06(-2.94%) | 10 Day Moving Average | $3.21(-7.48%) | 20 Day Moving Average | $4.55(-34.73%) | To recent high | -66.2% | To recent low | 4% | Market Cap | $221m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |